PDL Now Says It Will Consider Sale Of Entire Company
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO McDade formally steps down, while former board chairman Gage becomes interim CEO.
You may also be interested in...
PDL Ditches Cardene, Other Heart Failure Meds As Part Of Restructuring Plan
In a surprise move, former ESP Pharma executive snaps assets back up from PDL at what some consider a bargain-basement price.
PDL Ditches Cardene, Other Heart Failure Meds As Part Of Restructuring Plan
In a surprise move, former ESP Pharma executive snaps assets back up from PDL at what some consider a bargain-basement price.
Otsuka Bolsters Oncology Portfolio With Acquisition Of PDL’s Busulfex
Otsuka acquires first-in-class oncology product with over $29 million in sales for year ended Sept. 30.